Women with diabetes
Women are especially affected by diabetes due to various biological, cultural, and socio-economic factors. These factors not only place women at a disadvantage in obtaining diagnosis and treatment, but also present them with unique risks and complications.
Moreover, children born to mothers with gestational diabetes are eight times more likely to develop diabetes, and the mothers have a 70% risk of redeveloping diabetes.
Novo Nordisk initiated a new focus on these issues along with the Danish Minister for
Development Cooperation, the Global Alliance for Women’s Health and the World Diabetes Foundation, at a leadership forum in 2008.
This initiative built on the findings from an expert meeting, co-hosted by the Global Alliance for Women’s Health and the World Diabetes Foundation, on ‘Women, diabetes and development’.
The forum, and the activities that are planned to implement its recommendations, is Novo Nordisk’s commitment as a partner in the global campaign, driven by the Danish Minister for Development, ‘Call to Action for gender equality ’.
Novo Nordisk is working with partners to conduct further research into women, diabetes and development. The company will also increase its focus on women and diabetes through other diabetes care activities in the developing world.
These include screening programmes and awareness campaigns.
